At close: 3:30:00 PM GMT+5:30
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Rajesh Madan B. Pharma | Chief Executive Officer | -- | -- | -- |
| Ms. Parul Choudhary | Compliance Officer & Company Secretary | -- | -- | -- |
| Dr. Aneek Gupta | Head of Operations | -- | -- | -- |
Medicamen Biotech Limited
1506, Chiranjiv Tower
43, Nehru Place
New Delhi, 110019
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 378
Description
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarial, vitamins and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.
Corporate Governance
Medicamen Biotech Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 10, 2025 at 10:59 AM UTC - February 14, 2025 at 12:00 PM UTC
Medicamen Biotech Limited Earnings Date
Recent Events
September 19, 2024 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
LINCOLN.NS Lincoln Pharmaceuticals Limited
918.85
-2.50%
PAR.NS Par Drugs and Chemicals Limited
224.50
-1.79%
KILITCH.NS Kilitch Drugs (India) Limited
323.20
-1.67%
HESTERBIO.NS Hester Biosciences Limited
2,388.85
-1.74%
VENUSREM.NS Venus Remedies Limited
340.45
+0.65%
KREBSBIO.NS Krebs Biochemicals & Industries Limited
108.00
-2.88%
BROOKS.NS Brooks Laboratories Limited
147.90
+2.00%
ERIS.NS Eris Lifesciences Limited
1,512.90
-0.64%
SAKAR.NS Sakar Healthcare Limited
318.00
-1.23%
ALRPD.PA Rapid Nutrition PLC
0.0440
+1.38%